Daraprim, an anti-parasitic medication, is best known for its connection to Martin Shkreli, the former CEO of Turing Pharmaceuticals. In August 2015, Mr. Shkreli purchased the rights to Daraprim and boosted the price of the drug from $13.50 a pill to $750 overnight.
Mr. Shkreli congratulated the students on reproducing the drug in a video message posted to YouTube on Thursday.
“These Australian students are proof that the 21st century economy will solve problems of human suffering through science and technology,” he said, according to Reuters. “We should congratulate these students for their interest in chemistry and I’ll be excited about what is to come in this [science, technology, engineering and mathematics]-focused 21st century.”
More articles on supply chain:
Trump picks Elaine Chao for transportation secretary: 7 things to know
How Amazon trains new warehouse workers in just 2 days
Ariad Pharma earns full FDA approval for cancer drug Iclusig
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
